Routines can be powerful tools to help people build a ‘new normal’ as pandemic restrictions lift. Routines can support creativity, boost health and provide meaningful activities and opportunities.
Inequality in coronavirus genomic surveillance delays the detection of globally significant variants of concern.
Camilo Freedman/ picture alliance via Getty Images
Improving genomic surveillance to better understand new variants as they arise in different parts of the world could prevent threats to vulnerable health systems and populations.
Many celebrities have expressed concerns about bodily autonomy while refusing COVID-19 vaccination.
Photo Illustration by Jakub Porzycki/NurPhoto via Getty Images
Just as access to vaccines was vastly more difficult for low-income countries, the same is now true for the virus’ treatments: at potentially great cost to the world.
WHO Director-General, Dr Tedros Adhanom Ghebreyesus, during a visit at Afrigen Formulation Facilities in Cape Town, South Africa.
BENOIT DOPPAGNE/BELGA MAG/AFP/GettyImages
Moves by Moderna and BioNTech to make vaccines themselves in African countries signal that the companies aren’t considering licensing its technology to a third party for local manufacture.
Only one in three of the children in our research project did their schoolwork on a laptop or computer.
A woman wears a face mask as she walks by the sculpture ‘The Illuminated Crowd’ on a street in Montréal. Vulnerable people may benefit from measures like face masks even after the COVID-19 pandemic.
THE CANADIAN PRESS/Graham Hughes
Decreases in respiratory infections during the pandemic suggest there may be a continued role for the selective, non-mandated use of measures like masks and social distancing even post-COVID-19.
A case of advanced liver pathology (hepatomegaly) due to schistosomiasis in a 5-year-old.
Prof Takafira Mduluza
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice and Primary Care, The University of Melbourne
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand